Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid versus linezolid for adult central nervous system tuberculosis
ChiCTR2300078025Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of contezolid and linezolid in meningeal tuberculosis and cerebral tuberculosis (CNS-TB) (2 arms), sponsored by Huashan Hospital. Primary endpoints: Pharmacokinetics, Early clinical response rate and 2 more. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
contezolidlinezolid
03
Conditions
meningeal tuberculosiscerebral tuberculosis (CNS-TB)
Beyond the preview
Go deeper on ChiCTR2300078025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078025.